UBS Group’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Buy
26,773
+17,761
+197% +$331K ﹤0.01% 6061
2025
Q4
$142K Sell
9,012
-37,549
-81% -$547K ﹤0.01% 6744
2025
Q3
$619K Buy
46,561
+39,733
+582% +$348K ﹤0.01% 5925
2025
Q2
$58.1K Sell
6,828
-20,605
-75% -$133K ﹤0.01% 7654
2025
Q1
$108K Sell
27,433
-164
-0.6% -$833 ﹤0.01% 6994
2024
Q4
$160K Buy
27,597
+15,120
+121% +$73K ﹤0.01% 6596
2024
Q3
$49.9K Sell
12,477
-27,612
-69% -$145K ﹤0.01% 6825
2024
Q2
$237K Buy
40,089
+38,788
+2,981% +$201K ﹤0.01% 5547
2024
Q1
$5.27K Buy
+1,301
New +$6.29K ﹤0.01% 7553
2023
Q3
Sell
-27
Closed -$363 9853
2023
Q2
$363 Buy
+27
New +$353 ﹤0.01% 8276
2023
Q1
Sell
-82
Closed -$2.46K 10201
2022
Q4
$2.46K Buy
+82
New +$3.32K ﹤0.01% 9678
2022
Q3
Sell
-114
Closed -$7K 10793
2022
Q2
$7K Buy
+114
New +$8.13K ﹤0.01% 8516

Other funds holding PRE

UBS Group's PRE Position: Q1 2026 in Review

UBS Group increased its Prenetics Global (PRE) stake by 197% in Q1 2026, buying an estimated $331K and bringing the position to 26,773 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #6061.

UBS Group first reported a position in PRE in Q2 2022 and has held it in 12 quarters since. The position peaked at $619K in Q3 2025. 34 funds tracked by Wall St. Rank hold PRE as of Q1 2026.

  • UBS Group held 26,773 shares of Prenetics Global worth $517K as of Q1 2026.
  • UBS Group bought 17,761 Prenetics Global shares in Q1 2026, an estimated $331K.
  • Prenetics Global made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6061 holding.
  • UBS Group first reported a position in Prenetics Global in Q2 2022 and has held it in 12 quarters since.
  • UBS Group's Prenetics Global position peaked at $619K in Q3 2025.
  • 34 funds tracked by Wall St. Rank held Prenetics Global as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.